Rafferty Asset Management
CTIC

Rafferty Asset Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Rafferty Asset Management’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,136,381
Closed -$4.77M – 1172
2023
Q1 		$4.77M Sell
1,136,381
-334,976
-23% -$1.41M 0.03% 394
2022
Q4 		$8.84M Buy
1,471,357
+378,314
+35% +$2.27M 0.07% 218
2022
Q3 		$6.36M Buy
1,093,043
+655,442
+150% +$3.81M 0.07% 267
2022
Q2 		$2.61M Buy
+437,601
New +$2.61M 0.02% 413